Physicians' Experiences of EHR Technical Quality: Results from Four Large Cross-Sectional Surveys in 2010-2021.

Autor: Lääveri T; Aalto University, Department of Computer Science, Finland.; Inflammation Center, Helsinki University Hospital, Finland., Viitanen J; Aalto University, Department of Computer Science, Finland., Reponen J; Research Unit of Health Sciences and Technology, University of Oulu, Finland., Renko J; Oy Apotti Ab, Helsinki, Finland.

Publikováno v: Studies in health technology and informatics [Stud Health Technol Inform] 2024 Aug 22; Vol. 316, pp. 23-27.

Stable Levels of Antibodies Against Unrelated Toxoid Vaccines After COVID-19: COVID-19 Infection Does Not Affect Toxoid Vaccine Antibody Levels.

Autor: Jokiranta ST; Department of Bacteriology and Immunology, University of Helsinki, Helsinki, Finland.; Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Miettinen S; Viral Zoonosis Research Unit, Medicum, Department of Virology, University of Helsinki, Helsinki, Finland.; Department of Veterinary Biosciences, University of Helsinki, Helsinki, Finland., Salonen S; HUS Diagnostic Center, Clinical Microbiology, Helsinki University Hospital, Helsinki, Finland., Kareinen L; Department of Veterinary Biosciences, University of Helsinki, Helsinki, Finland.; Department of Virology, Medicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Finnish Food Authority, Helsinki, Finland., Uusitalo R; Department of Veterinary Biosciences, University of Helsinki, Helsinki, Finland.; Department of Virology, Medicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Korhonen EM; Department of Veterinary Biosciences, University of Helsinki, Helsinki, Finland.; Department of Virology, Medicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Virtanen J; Department of Veterinary Biosciences, University of Helsinki, Helsinki, Finland.; Department of Virology, Medicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Kivistö I; Department of Veterinary Biosciences, University of Helsinki, Helsinki, Finland.; Department of Virology, Medicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Aaltonen K; Department of Veterinary Biosciences, University of Helsinki, Helsinki, Finland.; Department of Virology, Medicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Mosselhy DA; Department of Veterinary Biosciences, University of Helsinki, Helsinki, Finland.; Department of Virology, Medicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Microbiological Unit, Fish Diseases Department, Animal Health Research Institute, ARC, Dokki, Giza 12618, Egypt., Lääveri T; Infectious Diseases, Inflammation Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Aalto University, Department of Computer Science, School of Science, Espoo, Finland., Kantele A; Human Microbiome Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Meilahti Infectious Diseases and Vaccine Research Center, MeiVac, Department of Infectious Diseases, University of Helsinki, Helsinki, Finland., Arstila TP; Department of Bacteriology and Immunology, University of Helsinki, Helsinki, Finland.; Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Jarva H; Department of Bacteriology and Immunology, University of Helsinki, Helsinki, Finland.; Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; HUS Diagnostic Center, Clinical Microbiology, Helsinki University Hospital, Helsinki, Finland., Vapalahti O; Viral Zoonosis Research Unit, Medicum, Department of Virology, University of Helsinki, Helsinki, Finland.; Department of Veterinary Biosciences, University of Helsinki, Helsinki, Finland.; HUS Diagnostic Center, Clinical Microbiology, Helsinki University Hospital, Helsinki, Finland.; Department of Virology, Medicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland., Heinonen S; New Children's Hospital, Pediatric Research Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Kekäläinen E; Department of Bacteriology and Immunology, University of Helsinki, Helsinki, Finland.; Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; HUS Diagnostic Center, Clinical Microbiology, Helsinki University Hospital, Helsinki, Finland.

Publikováno v: Pathogens & immunity [Pathog Immun] 2024 Feb 07; Vol. 8 (2), pp. 74-87. Date of Electronic Publication: 2024 Feb 07 (Print Publication: 2023).

Long COVID-associated symptoms prevalent in both SARS-CoV-2 positive and negative individuals: A prospective follow-up study.

Autor: Kantele A; Meilahti Infectious Diseases and Vaccine Research Center, MeiVac, Biomedicum 1, Haartmaninkatu 8, Helsinki University Hospital and University of Helsinki, 00290, Helsinki, Finland.; Department of Infectious Diseases, Helsinki University Hospital, Helsinki, Finland.; Human Microbiome Research Program, Faculty of Medicine, Haartmaninkatu 4, 00014, University of Helsinki, Helsinki, Finland., Paajanen J; Department of Pulmonary Medicine, Heart and Lung Center, Helsinki University Hospital and University of Helsinki, Finland., Pietilä JP; Meilahti Infectious Diseases and Vaccine Research Center, MeiVac, Biomedicum 1, Haartmaninkatu 8, Helsinki University Hospital and University of Helsinki, 00290, Helsinki, Finland.; Human Microbiome Research Program, Faculty of Medicine, Haartmaninkatu 4, 00014, University of Helsinki, Helsinki, Finland., Vapalahti O; Viral Zoonoses Research Unit, Departments of Virology and Veterinary Biosciences, Faculties of Medicine and Veterinary Medicine, 00014, University of Helsinki, Helsinki, Finland.; Helsinki University Hospital Diagnostic Center, HUSLAB, Clinical Microbiology, Topeliuksenkatu 32, 00290, Helsinki, Finland., Pakkanen SH; Meilahti Infectious Diseases and Vaccine Research Center, MeiVac, Biomedicum 1, Haartmaninkatu 8, Helsinki University Hospital and University of Helsinki, 00290, Helsinki, Finland.; Human Microbiome Research Program, Faculty of Medicine, Haartmaninkatu 4, 00014, University of Helsinki, Helsinki, Finland., Lääveri T; Meilahti Infectious Diseases and Vaccine Research Center, MeiVac, Biomedicum 1, Haartmaninkatu 8, Helsinki University Hospital and University of Helsinki, 00290, Helsinki, Finland.; Human Microbiome Research Program, Faculty of Medicine, Haartmaninkatu 4, 00014, University of Helsinki, Helsinki, Finland.; Department of Infectious Diseases, Helsinki University Hospital, Helsinki, Finland.; Helsinki University Hospital Diagnostic Center, HUSLAB, Clinical Microbiology, Topeliuksenkatu 32, 00290, Helsinki, Finland.; Department of Computer Science, Aalto University, PO Box 15400, FI-00076, AALTO, Finland.

Publikováno v: New microbes and new infections [New Microbes New Infect] 2023 Dec 07; Vol. 56, pp. 101209. Date of Electronic Publication: 2023 Dec 07 (Print Publication: 2024).

A prospective study of travellers' diarrhoea: analysis of pathogen findings by destination in various (sub)tropical regions

Autor: Lääveri, T., Vilkman, K., Pakkanen, S.H., Kirveskari, J., Kantele, A.

Publikováno v: In Clinical Microbiology and Infection August 2018 24(8):908-908

Superspreading of SARS-CoV-2 Omicron BA.2.23 among vaccinated Finnish adults: symptomatic COVID-19 only contracted by those without recent infection.

Autor: Riekkinen M; Department of Infectious Diseases, Inflammation Centre, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.; Human Microbiome Research Unit, University of Helsinki, Helsinki, Finland.; Meilahti Vaccine Research Centre, MeVac, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Kajova M; Department of Infectious Diseases, Inflammation Centre, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.; Human Microbiome Research Unit, University of Helsinki, Helsinki, Finland.; Meilahti Vaccine Research Centre, MeVac, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Eriksson M; Department of Infectious Diseases, Inflammation Centre, Helsinki University Hospital and University of Helsinki, Helsinki, Finland., Luukkainen A; Department of Infectious Diseases, Inflammation Centre, Helsinki University Hospital and University of Helsinki, Helsinki, Finland., Holmberg V; Department of Infectious Diseases, Inflammation Centre, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.; Human Microbiome Research Unit, University of Helsinki, Helsinki, Finland., Aro T; Department of Infectious Diseases, Inflammation Centre, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.; Human Microbiome Research Unit, University of Helsinki, Helsinki, Finland., Pakkanen SH; Human Microbiome Research Unit, University of Helsinki, Helsinki, Finland.; Meilahti Vaccine Research Centre, MeVac, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Miettinen S; Department of Virology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; HUS Diagnostic Centre, HUSLAB, Clinical Microbiology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Montonen R; Department of Virology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; HUS Diagnostic Centre, HUSLAB, Clinical Microbiology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Smura T; Department of Virology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; HUS Diagnostic Centre, HUSLAB, Clinical Microbiology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Lääveri T; Department of Infectious Diseases, Inflammation Centre, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.; Human Microbiome Research Unit, University of Helsinki, Helsinki, Finland.; Department of Computer Science, Aalto University, Espoo, Finland., Kantele A; Department of Infectious Diseases, Inflammation Centre, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.; Human Microbiome Research Unit, University of Helsinki, Helsinki, Finland.; Meilahti Vaccine Research Centre, MeVac, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Publikováno v: Epidemiology and infection [Epidemiol Infect] 2023 Jul 04; Vol. 151, pp. e113. Date of Electronic Publication: 2023 Jul 04.